Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2003
12/24/2003CN1462806A Main effective gene sites and molecule markers of wheat ÔÇÿNanda 2419ÔÇÖ for anti intrusion and infection by gibberellic disease
12/24/2003CN1462805A Optimization method for estimating genetic diversity and differentiation parameters of inheritance for marker group of dominant molecules
12/24/2003CN1462804A Filtering out non essential segment in copying adenovirus of birds, and its gene engineering products
12/24/2003CN1462803A Technqiue for preapring small interfering expression vector of ribonucleic acid of mammal cell
12/24/2003CN1462801A Nucleotide specific to O antigen of O52 colibacillus
12/24/2003CN1462635A Microzyme vaccine and bacterin for SARS epidemical tissue and its manufacturing method
12/24/2003CN1132011C Method for determining ready compound able to regulate cell proliferative diseases
12/24/2003CA2723500A1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
12/24/2003CA2722998A1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
12/24/2003CA2702194A1 Gradient structures interfacing microfluidics and nanofluidics, methods for fabrication and uses thereof
12/24/2003CA2492504A1 Identification of tissue/cell specific marker genes and use thereof
12/24/2003CA2492502A1 In vitro screening of cellular events using 3d cell culture systems
12/24/2003CA2490466A1 Systems and methods for predicting oligonucleotide melting temperatures (tms)
12/24/2003CA2489764A1 Method for detecting increased susceptibility to tumours
12/24/2003CA2489733A1 Complexity management of genomic dna by locus specific amplication
12/24/2003CA2489726A1 Diagnosis and treatment of chemoresistant tumors
12/24/2003CA2489605A1 Oxaliplatin anti-resistance agent
12/24/2003CA2489594A1 Inhibitors of inflammatory gene activity and cholesterol biosynthesis
12/24/2003CA2489474A1 Method for predicting a drug transport capability by abcg2 polymorphisms
12/24/2003CA2489346A1 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis a viral nucleic acid
12/24/2003CA2489296A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation
12/24/2003CA2489230A1 Bacterial test method by glycated label binding
12/24/2003CA2488858A1 Immunotoxin as a therapeutic agent and uses thereof
12/24/2003CA2488811A1 Oligosaccharide biomarkers for mucopolysaccharidoses and other related disorders
12/24/2003CA2488708A1 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
12/24/2003CA2488705A1 A nanoporous particle with a retained target
12/24/2003CA2487836A1 Metabolic phenotyping
12/24/2003CA2487809A1 Aptamer-toxin molecules and methods for using same
12/24/2003CA2486420A1 Compositions and methods for detecting hepatitis b virus
12/24/2003CA2473079A1 Methods and devices for the detection of pathogenic microorganisms and their antimicrobial susceptilbility
12/24/2003CA2464109A1 Process for the preparation of oxazolidinones and method of use thereof
12/23/2003US6667291 Endometrial Steroid Binding Protein II activity; endometrial and breast cancers
12/23/2003US6667176 cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
12/23/2003US6667175 Allospecific human suppressor CD8+CD28- T cells.
12/23/2003US6667168 PAK4, a novel gene encoding a serine/threonine kinase
12/23/2003US6667165 Method and compositions for reversible inhibition of thermostable polymerases
12/23/2003US6667164 Method for determining the MHC genotype of chickens
12/23/2003US6667163 Genetic engineering
12/23/2003US6667162 Isolating the Fkhsf polypeptide from cultured recombinant host cells.
12/23/2003US6667161 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same
12/23/2003US6667159 Optical fiber biosensor array comprising cell populations confined to microcavities
12/23/2003US6667155 Particle for the detection of preferential nucleotide sequences; for monitoring treatment of viral diseases
12/23/2003US6667154 Contacting with an oligo- or polynucleotide that hybridizes to a specific sequence and comparing the amount of polynucleotide that hybridizes to the oligonucleotide to a predetermined cut-off value
12/23/2003US6667153 Composition and method for detecting mutagens
12/23/2003US6667152 Method for selective inactivation of viral replication
12/23/2003US6667150 Screening for polyphage particles that contain the combination; the two members of the multimeric polypeptide complex interact to form an immunoglobulin, and wherein said predetermined property is the ability to bind to a target
12/23/2003CA2322073C Method for the non-specific amplification of nucleic acid
12/23/2003CA2279486C Method for identifying inducers and inhibitors of programmed cell death
12/23/2003CA2173861C Reaction tube and method of use to minimize contamination
12/21/2003CA2432777A1 Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques
12/20/2003CA2431579A1 Labeling of objects to be identified consisting of at least one dna fragment
12/18/2003WO2003105183A1 System and method for the preparation of arrays of biological or other molecules
12/18/2003WO2003104818A1 Method for identifying agonists or antagonists for the g-protein coupled mas-like 1 receptor
12/18/2003WO2003104815A1 Method of assay by oxidation-reduction reaction with formazan
12/18/2003WO2003104811A2 Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseases
12/18/2003WO2003104803A2 Method for mapping and eliminating t-cell epitopes
12/18/2003WO2003104793A1 Electrochemical biosensor
12/18/2003WO2003104789A1 MULTIFUNCTIONAL BIOSENSOR BASED ON ZnO NANOSTRUCTURES
12/18/2003WO2003104772A1 A disposable cartridge for characterizing particles suspended in a liquid
12/18/2003WO2003104771A1 Lysing reagent, cartridge and automatic electronic cell counter for simultaneous enumeration of different types of white blood cells
12/18/2003WO2003104770A2 A disposable cartridge for characterizing particles suspended in a liquid
12/18/2003WO2003104766A2 Method for enhancing dna base-calling accuracy
12/18/2003WO2003104762A2 Protein micro-arrays and multi-layered affinity interaction detection
12/18/2003WO2003104685A2 Fluorescent entity comprising a fluorophore covalently attached to at least one oligonucleotide and comprising at least one functional group, and uses thereof
12/18/2003WO2003104496A1 Type i interferon-inducible proteins to detect viral infection
12/18/2003WO2003104493A1 Improvements in and relating to a method of dna testing for mycobacterium paratuberculosis strains
12/18/2003WO2003104492A1 Marker assisted selection of bovine for improved milk composition
12/18/2003WO2003104491A1 Method of distinguishing rice varieties
12/18/2003WO2003104490A2 Method for the simultaneous detection of hybridization and vaccination reactions and diagnostic uses thereof
12/18/2003WO2003104489A2 Mchr1 variant associated with human obesity
12/18/2003WO2003104488A1 Eef1a2 for use in the prognosis, diagnosis and treatment of cancer
12/18/2003WO2003104487A2 Detection of epigenetic abnormalities and diagnostic method based thereon
12/18/2003WO2003104486A1 Method of selectively measuring triglycerides
12/18/2003WO2003104485A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
12/18/2003WO2003104484A1 Methods of treating and diagnosing diabetes with cx3cr1 modulators
12/18/2003WO2003104483A2 Methods and compositions for the identification of modulators of deoxyxylulose 5-phosphate synthase activity
12/18/2003WO2003104481A2 Methods
12/18/2003WO2003104480A1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor
12/18/2003WO2003104479A2 Identification of inhibitors of mitosis
12/18/2003WO2003104478A2 Detection of rna structural elements
12/18/2003WO2003104476A2 Assay to detect replication competent viruses
12/18/2003WO2003104474A2 Large deletions in human brca1 gene and use thereof
12/18/2003WO2003104459A1 Fcyriia transgenic animal model for autoimmune disease
12/18/2003WO2003104454A1 Novel oxidase
12/18/2003WO2003104452A1 Method of distinguishing gene participating in stigma exposure ratio in rice and method of modifying stigma exposure ratio in rice
12/18/2003WO2003104447A1 Fluorescent detection of peroxidase enzymes
12/18/2003WO2003104434A2 A method to amplify variable sequences without imposing primer sequences
12/18/2003WO2003104431A2 Transgenic mammals expressing polyglutamine
12/18/2003WO2003104427A2 Methods and compositions for detecting cancers
12/18/2003WO2003104426A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof
12/18/2003WO2003104424A2 Novel molecular conjugates for signal amplification
12/18/2003WO2003104420A2 Electrochemical detection of single nucleotide polymorphisms (snps)
12/18/2003WO2003104407A2 T cell receptor cdr3 sequences and methods for detection
12/18/2003WO2003104406A2 Improvements for combinatorial oligonucleotide pcr
12/18/2003WO2003104399A2 Cancer-linked gene as target for chemotherapy
12/18/2003WO2003104398A2 Allelic variation in human gene expression
12/18/2003WO2003104383A1 Kit and process for microbiological for on-site examination of a liquid sample
12/18/2003WO2003104262A2 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells
12/18/2003WO2003104259A2 PEPTIDES PRESENTED BY HLA-B18 AND Cw16 MOLECULES, AND USES THEREOF
12/18/2003WO2003104251A2 Composition and methods for obtaining nucleic acids from sputum
1 ... 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 ... 3003